🧪 Hypotheses

mechanistic 0.96

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

🧬 GRIN2B 🏥 neuroscience 📖 19🏛 4

✅ 0.85 ✨ 0.78 💥 0.82

## Mechanistic Overview...

therapeutic 0.95

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic d

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.00 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.91

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholecystokinin interneuron ne

🧬 CCK 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.00 ✨ 0.64 💥 0.00

## Mechanistic Overview...

unknown 0.89

Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse

🧬 SLC16A1, SLC16A7, LDHA, PDHA1 🏥 neurodegeneration 📖 9🏛 1

✅ 0.70 ✨ 0.62 💥 0.68

## Mechanistic Overview...

mechanistic 0.89

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence

🧬 SIRT1 🏥 neurodegeneration 📖 54🏛 3

✅ 0.80 ✨ 0.70 💥 0.76

## Mechanistic Overview...

mechanistic 0.89

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

🧬 TREM2 🏥 neurodegeneration 📖 1🏛 3

✅ 0.68 ✨ 0.72 💥 0.82

## Mechanistic Overview...

unknown 0.89

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration

🧬 IFNG 🏥 neurodegeneration 📖 10🏛 1

✅ 0.50 ✨ 0.75 💥 0.75

## Mechanistic Overview...

unknown 0.89

TREM2-APOE Axis Dissociation for Selective DAM Activation

🧬 TREM2-APOE axis 🏥 neurodegeneration 📖 12🏛 1

✅ 0.35 ✨ 0.78 💥 0.68

## Mechanistic Overview...

combination 0.88

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

🧬 MAPK14/PRMT1 🏥 neurodegeneration 📖 16🏛 1

✅ 0.78 ✨ 0.65 💥 0.82

## Mechanistic Overview...

unknown 0.87

Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Specific ceRNA Networks

🧬 PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway 🏥 molecular neurobiology 📖 9🏛 1

✅ 0.55 ✨ 0.70 💥 0.65

## Mechanistic Overview...

combination 0.86

Glymphatic-Mediated Tau Clearance Dysfunction

🧬 MAPT 🏥 neuroscience 📖 17🏛 3

✅ 0.68 ✨ 0.85 💥 0.78

## Mechanistic Overview...

unknown 0.86

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

🧬 NAMPT 🏥 neurodegeneration 📖 10🏛 1

✅ 0.50 ✨ 0.65 💥 0.75

## Mechanistic Overview...

combination 0.86

TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance

🧬 TREM2 🏥 neuroscience 📖 18🏛 4

✅ 0.00 ✨ 0.49 💥 0.00

## Mechanistic Overview...

therapeutic 0.86

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 27🏛 2

✅ 0.90 ✨ 0.75 💥 0.80

## Mechanistic Overview...

unknown 0.86

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

🧬 EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B 🏥 neurodegeneration 📖 9🏛 1

✅ 0.92 ✨ 0.70 💥 0.90

## Mechanistic Overview...

unknown 0.84

TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection

🧬 TYROBP 🏥 neurodegeneration 📖 16🏛 1

✅ 0.28 ✨ 0.82 💥 0.58

## Mechanistic Overview...

unknown 0.84

miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglial State Transition

🧬 MIR155 🏥 neurodegeneration 📖 14🏛 1

✅ 0.35 ✨ 0.80 💥 0.65

## Mechanistic Overview...

unknown 0.84

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

🧬 SST, SSTR1, SSTR2 🏥 neurodegeneration 📖 7🏛 1

✅ 0.85 ✨ 0.72 💥 0.82

## Mechanistic Overview...

unknown 0.84

Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the Self-Amplifying Iron-Ferroptos

🧬 Labile iron pool (deferoxamine target) and GPX4 (sulforaphane target) 🏥 neurodegeneration 📖 9🏛 1

✅ 0.60 ✨ 0.55 💥 0.70

## Mechanistic Overview...

unknown 0.84

Gamma Oscillation Enhancement Synergy

🧬 N/A 🏥 neurodegeneration 📖 9🏛 1

✅ 0.45 ✨ 0.78 💥 0.65

## Mechanistic Overview...

mechanistic 0.83

IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface

🧬 IL6R, IL6 🏥 neuroinflammation 📖 12🏛 1

✅ 0.72 ✨ 0.65 💥 0.80

## Mechanistic Overview...

combination 0.83

Microglial-Mediated Tau Clearance Dysfunction via TREM2 Signaling

🧬 TREM2 🏥 neuroscience 📖 2🏛 3

✅ 0.70 ✨ 0.65 💥 0.85

## Mechanistic Overview...

mechanistic 0.82

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegenera

🧬 NLRP3, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.62 ✨ 0.50 💥 0.00

## Mechanistic Overview...

unknown 0.82

TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation

🧬 TREM2/TYROBP 🏥 neurodegeneration 📖 10🏛 2

✅ 0.88 ✨ 0.65 💥 0.85

## Mechanistic Overview...

therapeutic 0.81

Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation

🧬 HCAR2 🏥 neurodegeneration 📖 11🏛 1

✅ 0.82 ✨ 0.70 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A 📖 10🏛 1

✅ 0.00 ✨ 0.41 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration

🧬 AIM2, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 31🏛 1

✅ 0.66 ✨ 0.52 💥 0.00

## Mechanistic Overview...

unknown 0.80

pH-Sensitive Bispecific Antibody Targeting Transferrin Receptor for CNS Delivery

🧬 TFRC (TfR1); endosomal acidification pathway 🏥 neurodegeneration 📖 8🏛 1

✅ 0.78 ✨ 0.82 💥 0.88

## Mechanistic Overview...

unknown 0.80

Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector

🧬 MANF, CDNF 🏥 neurodegeneration 📖 13🏛 1

✅ 0.48 ✨ 0.68 💥 0.62

## Mechanistic Overview...

mechanistic 0.79

Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs)

🧬 APOE 🏥 neurodegeneration 📖 87🏛 2

✅ 0.20 ✨ 0.90 💥 0.70

## Mechanistic Overview...